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Abstract
LFA-1 is a leukocyte specific b2 integrin that plays a major role in regulating adhesion and migration of different immune
cells. Recent data suggest that LFA-1 on mature dendritic cells (mDCs) may function as a chemokine-inducible anchor
during homing of DCs through the afferent lymphatics into the lymph nodes, by transiently switching its molecular
conformational state. However, the role of LFA-1 mobility in this process is not yet known, despite that the importance of
lateral organization and dynamics for LFA-1-mediated adhesion regulation is broadly recognized. Using single particle
tracking approaches we here show that LFA-1 exhibits higher mobility on resting mDCs compared to monocytes. Lymphoid
chemokine CCL21 stimulation of the LFA-1 high affinity state on mDCs, led to a significant reduction of mobility and an
increase on the fraction of stationary receptors, consistent with re-activation of the receptor. Addition of soluble monomeric
ICAM-1 in the presence of CCL21 did not alter the diffusion profile of LFA-1 while soluble ICAM-1 nano-aggregates in the
presence of CCL21 further reduced LFA-1 mobility and readily bound to the receptor. Overall, our results emphasize the
importance of LFA-1 lateral mobility across the membrane on the regulation of integrin activation and its function as
adhesion receptor. Importantly, our data show that chemokines alone are not sufficient to trigger the high affinity state of
the integrin based on the strict definition that affinity refers to the adhesion capacity of a single receptor to its ligand in
solution. Instead our data indicate that nanoclustering of the receptor, induced by multi-ligand binding, is required to
maintain stable cell adhesion once LFA-1 high affinity state is transiently triggered by inside-out signals.
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Introduction
Leukocyte specific integrins are a subfamily of heterodimeric a/
b transmembrane receptors involved in adhesion and migration of
white blood cells. These receptors allow leukocytes to act upon the
detection of potential threats to the body by enabling rapid
anchoring of leukocytes to the inner wall of blood vessels. This
process is followed by leukocyte migration from the bloodstream to
the site of inflammation. In a subsequent step of the immunolog-
ical cascade, leukocytes stably adhere to other immune cells to
communicate the detected threat [1–4]. Lymphocyte Function-
associated Antigen-1 (LFA-1) is a member of the leukocyte specific
integrin family, and belongs to the subgroup of b2 integrins. This
receptor has been found on the membrane of multiple types of
leukocytes [5], including lymphocytes, monocytes, and dendritic
cells. The main binding partner of LFA-1 is Intercellular Adhesion
Molecule-1 (ICAM-1), which is highly expressed on activated
endothelial cells and Antigen Presenting Cells (APCs) such as
dendritic cells [6,7]. LFA-1 facilitates rolling, arrest and transen-
dothelial migration during the extravasation of monocytes and
lymphocytes by binding to ICAM-1 on the endothelial cells [8,9].
The interaction between LFA-1 and ICAM-1 also plays a role in
the formation of the immunological synapse between lymphocytes
and APCs [10]. To successfully accomplish these different types of
adhesion in distinct cell types, tight regulation of LFA-1 activity is
crucial.
For a long time, affinity [11–13] as well as avidity [14,15] have
been recognized as important factors regulating LFA-1 activity.
Affinity refers to the adhesion capacity of a single receptor to its
ligand in solution, and it is determined by the molecular
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conformation of the receptor [11]. High resolution TEM data has
shown that LFA-1 can be found in at least three different
conformational states [11]: bent down with a low affinity for the
ligand, transiently extended with an intermediate affinity for the
ligand, and fully extended with a high affinity for the ligand [12].
Avidity, on the other hand, refers to the binding strength of a
multitude of receptors together that effectively contribute to
adhesion [14]. Affinity of the single molecules defines part of this
binding, but the extra component in avidity is determined by the
spatial organization of the receptors. Indeed, we have previously
shown on resting monocytes that organization of LFA-1 in
nanoclusters [15] and in hotspot regions together with lipid rafts
[16] contributes to avidity. More recently, we have also shown that
lateral diffusion of the receptor across the membrane is crucial in
the regulation of LFA-1 activity [17]. Using single molecule
approaches, we demonstrated that LFA-1 is primarily mobile on
resting monocytes with a small sub-population of stationary
nanoclusters [17]. Using conformation-dependent antibodies we
identified the small stationary LFA-1 sub-population as consisting
of extended activated molecules, while the mobile population is
mostly bent down and inactive. Importantly, we found that this
small subset of stationary activated LFA-1 molecules (accounting
for only 5% of the total LFA-1 population) is sufficient to initiate
sites for adhesion, being reinforced by the contribution of mobile
low-affinity nanoclusters [17].
During differentiation of monocytes into dendritic cells, LFA-1-
mediated binding to ICAM-1 is lost while expression levels of the
receptor remain constant [15,18]. Activating mature DCs (mDCs)
with chemokine CCL21 increases the population of extended
LFA-1 molecules and also restores LFA-1 adhesive properties [18].
CCL21, also known as SLC, is a chemokine that regulates the
homing of lymphocytes and dendritic cells from distant sites to
lymphoid tissues [19–21] via binding to its receptor CCR7
[22,23]. It has been shown in lymphocytes that soluble CCL21
triggers the high-affinity conformation of LFA-1 [24] and induces
binding of LFA-1 to its ligand ICAM-1 [25]. This functional data
on LFA-1 activation by chemokines suggest a dramatic change in
the modulation of receptor activity in the process of cell
differentiation and chemokine activation, i.e. from a loss to a
chemokine-induced transient regain of LFA-1 binding capacity.
Considering that LFA-1 conformation state and lateral diffusion
on the cell membrane are highly coupled [17,26], it is conceivable
that potential changes on the mobility of the receptor on mDCs
after CCL21 stimulation might contribute together with affinity to
the regain of LFA-1 functionality. Yet, dynamic studies of LFA-1
mobility on resting and chemokine activated mDCs supporting the
functional changes in adhesion and ligand binding [18,25] are
lacking so far. Moreover, how modulation of LFA-1 function
during differentiation is achieved and how CCL21 cooperates to
regulate LFA-1 activity on mDCs remains unknown. Here we
have performed systematic single particle tracking studies to
directly report on the lateral mobility of LFA-1 on both monocytes
and mDCs. We show that LFA-1 exhibits higher mobility on
resting mDCs compared to monocytes. CCL21 stimulation of the
high affinity state of LFA-1 on mDCs led to a significant reduction
of LFA-1 lateral mobility and an increase on the fraction of
stationary receptors, with overall diffusion profiles that closely
resemble those obtained on resting monocytes. Addition of soluble
monomeric ICAM-1 in the presence of CCL21 did not alter the
diffusion profile of LFA-1 while soluble ICAM-1 nano-aggregates
in the presence of CCL21 further reduced LFA-1 mobility. We
finally shed new light on how Talin1, a cytoplasmic protein known
to contribute to integrin function regulation and activation [24,27–
31] by binding the b2 subunit of LFA-1 to the actin cytoskeleton
[32,33], could be involved in b2 integrin activation. Our data
shows that Talin1 plays a different role in basal LFA-1 regulation
on monocytes and mDCs. Overall, our results underscore two
main features associated to LFA-1 activation and function. First,
lateral mobility of the receptor is directly correlated with its
activation state, with LFA-1 priming resulting in restricted lateral
diffusion. Second, chemokines are required but not sufficient to




Mature dendritic cells (mDC) were derived, as reported
previously [34], from peripheral blood samples. Buffy coats from
healthy donors were obtained from Banc de Sang I Teixits upon
written informed consent. In brief, peripheral blood mononuclear
cells (PBMCs) were allowed to adhere to a plastic surface for 2 h at
37uC. Unbound PBMCs were washed away, and the remaining
adherent monocytes were cultured for 5 days in a 37uC, 95%
humidity, 5% CO2 incubator in the presence of IL-4 (300 U/ml)
and GM-CSF (450 U/ml) (both from Miltenyi Biotec, Madrid,
Spain) in X-VIVO 15 (BioWhittaker, Lonza Belgium) medium
supplemented with 2% AB human serum (Sigma-Aldrich, Spain).
After 5 days, DCs were matured for 48 hours using a cocktail of
IL-1b, IL-6 (both at 1000 IU/ml), TNF-a (500 IU/ml) (all 3 from
CellGenix, Freiburg, Germany) and Prostaglandin E2 (PGE2,
10 mg/ml; Dinoprostona, Pfizer). mDCs were harvested and
brought to the proper concentration for subsequent experiments.
Monocytes in solution were positively selected from PBMCs
using anti-CD14 magnetic microbeads (Miltenyi Biotec, Madrid,
Spain).
Flow Cytometry
For flow cytometry analysis, mDCs were labeled with primary
antibody anti-CCR7 (R&D systems), followed by secondary
staining with PE-labelled goat-anti-mouse (from BD Pharmingen),
both for 30 min at 4uC and a concentration of 5 mg/ml.
Appropriate isotype control IgG1 (from BD Pharmingen), was
included. Flow cytometry was performed using FACSCanto II.
Sample Preparation for Single Dye Tracking (SDT)
Monocytes and mDCs were prepared to track individual LFA-1
molecules on the membrane. Chambered cover glasses (8 wells,
Nunc Lab-Tek II) were incubated with Poly-L-Lysine (10 mg/ml,
Sigma-Aldrich) for 30 min. Fresh cells were diluted up to a
concentration of 56105 per ml in RPMI, and attached to the
bottom of the cover glasses by incubation for 30 min. Unbound
cells were washed away, and the sample was blocked for 15 min
with 2% of HS in RPMI at 37uC. LFA-1 was then labeled by
incubation with TS2/4-Atto647N conjugates in a concentration of
0.01 mg/mL for 3.5 min to allow for single dye tracking
experiments, i.e., at sub-labeling conditions. Afterwards, the
sample was washed thoroughly and 350 ml of RPMI per well
was used as imaging medium. All incubation steps were done at
37uC and washing in between steps was done with RPMI without
supplements. During the experiments where mDCs were activat-
ed, 50 ml CCL21 (final concentration in experiments 1 mg/ml;
Recombinant Human CCL21/6Ckine, R&D systems) was added
during the measurements and mobility was measured before and
up to 10 min after addition at one-minute intervals. Experiments
is which mDCs and monocytes were stimulated with ICAM-1
were designed similarly, using either 1 mg ICAM-1 monomers in
50 ml RPMI (Recombinant Human, R&D systems) (a concentra-
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tion known to saturate high affinity LFA-1 on lymphocytes [35]),
or 50 ml ICAM-1 nano-aggregates (100 mg/ml ICAM-1 incubated
for 30 min at 37uC with 100 mg/ml polyclonal anti-ICAM-1
(Santa Cruz) [16]) with a final experimental concentration of
20 mg/ml. In combination experiments, 50 ml RPMI containing a
cocktail of ICAM-1 and CCL21 was added to the samples.
Single Dye Tracking
Freshly prepared samples were placed on the microscope setup,
and movies of typically 300 frames with a frame rate of 10 Hz
were recorded. We used a home build setup arranged around an
inverted microscope (IX70, Olympus) with a 1.45 NA oil
immersion objective (PLAPON 6060TIRFM, Olympus). Samples
were illuminated using a 633 nm HeNe laser (circularly polarized
light, 1.4 kW/cm2) in oblique illumination mode to excite the
samples slightly above the glass-cell interface, minimizing in this
way any potential artifacts associated with the proximity of the cell
membrane to the glass substrate. The fluorescence emission of the
ATTO-647N was separated from the excitation light using a
dichroic mirror (Semrock, FF500/646-Di01). A 660 nm long pass
filter (Semrock, BLP01-635R-25) then selectively allowed the
fluorescent emitted light to be detected by an EMCCD
(Hamamatsu) camera. Temperature was maintained at 37uC with
5% CO2 by a custom made incubator built around the microscope
stage. In experiments where cells were stimulated with CCL21
and/or ICAM-1, movies of 30 s were recorded before, and at one-
minute intervals after stimulation up to 10 minutes.
Single Trajectory Analysis
Analysis was done as previously described [17]. In brief, two-
dimensional trajectories in the plane of focus were reconstructed
based on a colloidal particle-tracking algorithm translated to
MatLab. For each individual trajectory longer than 13 frames, a
mean square displacement (MSD) curve was generated and the
diffusion coefficient was calculated using a linear fitting through
the second to the fourth point (D2–4). A semi-logarithmic
histogram was generated containing the short-time lag (D2–4)
diffusion coefficients from multiple trajectories in different cells.
Since the mobility was rather slow and the cells were extensively
stretched, typically around 150 trajectories were recovered per
cell. The cut-off value to define the mobile population was
calculated by generating a similar histogram on fixed cells, and
defining the diffusion coefficient for which 95% of the fixed
population had a lower or equal D value. In our experimental
conditions, the cut-off value was D#0.001 mm2/s.
We then generated an overall mean square displacement plot of
the total mobile population up to a time lag of 2 seconds. A linear
fitting through the first 4 points was used to define the average
diffusion coefficient of the mobile LFA-1 population. In addition,
we also used Cumulative Probability Distribution (CPD) analysis
as described earlier by us [17] to separate the mobile LFA-1
population into 2 different subpopulations or fractions: slow and
fast. The percentage of each fraction within the total mobile
population was estimated, and the diffusion coefficient of each
fraction was calculated as described above. Individual data points
are the mean value of all trajectories measured per each cell.
Sample Preparation for ICAM-1 Binding Assay
FluoroDishes (35 mm, World Precision Instruments) were
incubated with Poly-L-Lysine (10 mg/ml, Sigma-Aldrich) for
30 min. Fresh cells were diluted up to a concentration of 16106
per ml in RPMI, and attached to the bottom of the cover glasses
by incubation for 30 min. For the last 2 minutes, cells were
incubated with either ICAM-1 dimers (20 mg/ml ICAM-1
incubated for 30 min at 37uC with 20 mg/ml monoclonal anti-
ICAM-1 (BD Pharmingen)), ICAM-1 dimers plus CCL21 (1 mg/
ml), ICAM-1 nano-aggregates (20 mg/ml ICAM-1 incubated for
30 min at 37uC with 20 mg/ml polyclonal anti-ICAM-1 (Santa
Cruz)), or ICAM-1 nano-aggregates plus CCL21 (1 mg/ml).
Immediately after these 2 minutes, samples were fixed using 2%
paraformaldehyde (PFA) for 15 min at RT. Then, cells were
blocked for 1 h at RT with 3% BSA 2% HS and 20 mM glycine
in PBS, followed by primary labeling for 30 min at RT with 5 mg/
ml of either, in the case of the dimers, goat-anti-mouse-
ATTO647N or, in the case of the nano-aggregates, goat-anti-
rabbit-AF647 (Invitrogen). Finally all samples were fixed again
with 2% PFA.
Imaging ICAM-1 Binding
Imaging was performed using a confocal microscope (TCS SP5,
Leica Microsystems). Images were taken with a 1.4 NA oil
immersion objective (HCX PL APO CS 63.0x, Leica), a 5126512
pixel format and a scanning speed of 400 Hz. Both dimers labeled
with ATTO647N and aggregates labeled with AF647 were excited
with the 633 nm line at 35% of the HeNe laser power and
detected between 645 nm and 715 nm. Images of individual cells
were taken with a line accumulation of 3 times and a frame
average of 14 times.
Sample Preparation for Talin Localization Assay
Polydimethylsiloxane (PDMS) elastomer stamps were fabricated
by curing for 1–2 hours by 80uC Sylgard 184 (Dow Corning) in a
10:1 weight proportion (base: crosslinker), on a silanized silicon
patterned master (patterns of 2.562.5 mm) generated in photore-
sist using standard photolithography techniques. The cured
PDMS was peeled off the master and cut into 161 cm squares.
PDMS stamps were sonicated in ethanol for 10 min, rinsed with
milliQ water and blow dried with nitrogen gas. Stamps were
coated with 5 mg/ml of either mouse IgG1 (Sigma Aldrich), TS2/
4 (Biolegend) or 50 mg/ml F(ab)2 goat-anti-human (Jackson
Immunoresearch), and free Atto647N dye to visualize the location
of the positive areas. After 45 min of incubation, stamps were
rinsed with milliQ water, blown dry with nitrogen gas, and
stamped into clean (sonicated for 10 min. in 1:1 ethanol: miliQ)
and hydrophilic (10 min exposure to UV/Ozone Bioforce
nanosciences) glass coverslips (Menzel- Glaser Ø30 mm #1). A
circle with a DAKO pen was drawn to keep all subsequently used
solutions on the coverslip. After stamping, the negative areas on
the glass surface were blocked for 30 min. at 37uC with 3% bovine
serum albumin (BSA) in PBS to minimize unspecific binding. The
F(ab)2 goat-anti-human samples were subsequently incubated for 1
hour at 37u with 5 mg/ml ICAM-1. After washing with PBS, cells
were added in a concentration of 16106 per ml and were allowed
to adhere to the substrate for 30 min at 37uC. Part of the samples
were activated for the last 2 minutes with CCL21 (1mg/ml)
Afterwards, cells (monocytes or mDCs) were rapidly fixed with 2%
paraformaldehyde (PFA) for 15 min at RT, and permeabilized for
10 min RT with 0.05% Saponin (Sigma-Aldrich) in PBS with
10 mM glycine to allow intracellular labeling. After blocking for
20 min at RT with PBS 1% BSA, cells were labeled with 9 mg/ml
antiTalin-ATTO488 conjugates for 40 min at RT. Finally,
samples were fixed again and stored at 4uC until measurement.
Imaging Localization of Talin and LFA-1
Imaging was performed using a confocal microscope (TCS SP5,
Leica Microsystems). Images were taken with a 1.4 NA oil
immersion objective (HCX PL APO CS 63.0x, Leica), a 5126512
pixel format and a scanning speed of 400 Hz. AntiTalin-Atto488
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was excited with the 488 nm line, at 25% of the argon laser power
and detected between 500 nm and 570 nm. Atto647N (positive
squares) was excited with the 633 nm line at 4% of the HeNe laser
power and detected between 645 nm and 715 nm. Images of
individual cells were taken with a line accumulation of 3 times and
a frame average of 12 times, focusing on the contact area between
cell and substrate.
Analysis Localization of Talin to LFA-1
We used the fluorescent images of Talin (green) and positively
patterned areas (red) to quantify the degree of localization of Talin
to LFA-1. We first selected the cell area in both channels, and
created from the red channel a mask of the pattern (positive = 1,
negative = 0). We applied this mask to the green channel, and
calculated the average intensity per area of the green Talin signal
in each positive square. To define the degree of enhancement in
each positive area, this local average was divided by the average
green intensity per area of the entire negative part of the mask
covering the cell. To avoid artifacts, we excluded the negative
region just around (up to 10 pixels away) a positive region.
Statistical Analysis
All analyses were performed using GraphPad Prism 6. Results
are shown as the mean 6 SEM. To determine statistical
differences between the mean of two data sets (Figure 1), the
(un)paired two-tailed Student T-test was used. To determine
statistical differences between the mean of 3 or more data sets, the
One-way ANOVA was used, followed by the Tukey’s multiple
comparison test (Figures 2, 3 A–E, 4F and 4H). In the case of non-
Gaussian distributed data sets (Figure 4E and 4G), statistical
differences were calculated using the Kruskal-Wallis test, followed
by Dunn’s multiple comparison test. Significance is represented
using: ns (P.0.05); * (P,0.05); ** (P,0.001) and *** (P,0.0001).
Results
LFA-1 Mobility Increases During Differentiation of
Monocytes into mDCs
We have previously shown on resting monocytes that lateral
diffusion of LFA-1 across the membrane correlates with activation,
with low-affinity LFA-1 being primarily mobile and high-affinity
LFA-1 being immobile and anchored to the cytoskeleton [17,36].
Moreover, we also showed that LFA-1 becomes inactive upon
differentiation of monocytes into dendritic cells [15,18]. Based on
these results, we hypothesized that differences in LFA-1 activity
between monocytes and mDCs might be also reflected in the
lateral mobility of the receptor. We therefore recorded the
diffusive behavior of LFA-1 on both cell types using previously
established single particle tracking approaches [17]. We labeled
LFA-1 under sub-labeling conditions using the conformation-
independent antibody TS2/4 attached to the fluorophore
ATTO647N on both primary monocytes and mDCs. We then
recorded the mobility of individual diffusing fluorophores using a
single molecule set-up working under oblique illumination, and
subsequently reconstructed trajectories of the diffusing molecules.
Whereas some molecules were highly mobile, other molecules
showed much slower diffusion or were even stationary (Figure 1A,
Movie S1). Individual trajectories were analyzed by generating
mean square displacement (MSD) plots to obtain the diffusion
coefficient (D) at short time lags. Histograms of the D values of all
recovered trajectories on both cell types were created, displaying
the full distribution of the diffusive behavior of LFA-1 (Figure 1B).
A clear shift of the entire histogram towards higher D values is
observed on mDCs compared to monocytes indicating an overall
increase in lateral mobility of LFA-1 on mDCs. This increase on
mobility was also accompanied by a modest but reproducible
reduction on the stationary LFA-1 population (defined for values
below 0.001 mm2/s) from 15% on monocytes to 10% on mDCs
(Figure 1B, C).
To further enquire on the diffusive behavior of LFA-1 at longer
observation times, we applied cumulative probability distribution
(CPD) analysis [37]. This approach allowed us to separate the
entire mobile LFA-1 population into two different fractions,
namely a slow diffusing fraction and a fast diffusing fraction. We
then calculated the percentage of molecules belonging to each
fraction (stationary, slow or fast) (Figure 1C) and their respective
average diffusion coefficients D (Figure 1D). Overall, mDCs
exhibit a larger fraction of fast diffusing LFA-1 molecules at the
expense of a smaller fraction of slow diffusing and stationary ones,
compared to monocytes. Furthermore, the average diffusion
coefficients of both the slow and the fast diffusing fractions of
LFA-1 are considerably higher on mDCs than on monocytes.
Altogether, these results show that the mobility of LFA-1 increases
during differentiation of monocytes into mDCs and further
suggests that the loss of ligand binding capacity of LFA-1 on
mDCs might be correlated with its increased lateral mobility.
Chemokine-induced LFA-1 Reactivation on mDCs
Restricts LFA-1 Lateral Mobility
It is well established that chemokines trigger inside-out signaling
events [38,39] that lead to rapid LFA-1 activation and ICAM-1
mediated adhesion of lymphocytes [25] and mDCs [18]. We thus
sought to investigate whether chemokine stimulation alters the
diffusion profile of LFA-1 on mDCs. To this end, we reactivated
LFA-1 on mDCs using CCL21 [18,24,25], a chemokine that
regulates the homing of lymphocytes and dendritic cells from
distant sites to lymphoid tissues [19,20], and compared the
diffusive behavior of the receptor before and after CCL21
activation. As CCL21 acts via binding to CCR7 [22,23], we first
confirmed the high expression level of this receptor on mDCs
(Figure S1). Furthermore, because the activating effect of CCL21
on LFA-1 appears to be very rapid and transient within a few
minutes [25], we carefully adjusted our single particle tracking
experiments to measure LFA-1 mobility on mDCs 2 minutes after
activation with CCL21, a time point at which the highest increase
in LFA-1 dependent cell adhesion has been observed [25]. CCL21
stimulation significantly decreased LFA-1 mobility and increased
the stationary population (Figure 2A) as compared to resting
mDCs. Remarkably, the overall diffusion profile of chemokine-
triggered re-activated LFA-1 on mDCs fully overlaps with that
obtained on resting monocytes (Figure 2A). Indeed, a more
detailed analysis shows that the slow and fast fractions (Figure 2B)
as well as the diffusion coefficients thereof (Figure 2C) and
stationary fractions (Figure 2D) between activated LFA-1 on
mDCs and LFA-1 on resting monocytes entirely coincide.
To enquire whether the changes in LFA-1 mobility upon
CCL21 activation are as transient as the activation of the receptor,
we performed similar experiments at different time points after
activation. The change in the percentages between stationary, slow
and fast diffusing LFA-1 fractions (Figure 2E) as well as the change
in average diffusion coefficients of the different fractions (Figure 2F)
are indeed most prominent 2 minutes after activation. To fully
verify that these results are indeed a consequence of CCL21
stimulation and not arising from experimental variations, we
performed similar diffusion studies of LFA-1 at 1-minute intervals
on mDCs without CCL21 stimulation (Figure S2 and S3). These
controls, in which no significant differences are observed between
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indicated time points, confirm that the changes observed on mDC
after CCL21 stimulation are real and maximal after 2 minutes.
After 4 minutes, changes due to CCL21 treatment are
undetectable, indicating that the entire activation process is
extremely transient. These results thus indicate that the activation
state (i.e., ligand binding capacity) and mobility of LFA-1 are
tightly and temporally correlated. Indeed, it appears that the loss
of LFA-1 mediated cell adhesion during monocyte differentiation
into mDCs correlates with an increased mobility of the receptor
across the membrane. Transiently restoring LFA-1 adhesion
function by conformational activation results in an equally
transient decrease of mobility. In apparent contrast to our results,
Constantin et al. have suggested that chemokine stimulation should
trigger rapid integrin lateral mobility, which together with
immediate triggering of the high-affinity state would cooperate
in mediating rapid lymphocyte arrest under physiological condi-
tions [25]. The apparent discrepancies between these findings and
ours are discussed below.
Binding of ICAM-1 Nano-aggregates, but not Monomeric
ICAM-1, Magnifies Chemokine-induced Activation of LFA-
1
Whether chemokines alone are sufficient to induce the high
affinity state of LFA-1, or whether ligand binding is also necessary
to fully bring the receptor in a stable high affinity conformation is
not entirely clear. While some models suggest that chemokines
alone induce the high affinity form of the integrin independent of
ligand binding [25], others propose that chemokines trigger an
extended form of low-to-intermediate affinity that is followed by a
transition to a high affinity state upon interaction with the ligand
[24]. More recently, it has been shown that affinity of LFA-1 for
soluble monomeric ICAM-1 is only slightly increased upon LFA-1
priming by chemokines [40]. To shed some light into this
controversy we performed single particle tracking experiments of
LFA-1 in the presence of soluble monomeric ICAM-1, on resting
and CCL21-stimulated mDCs. In addition, we also recorded the
mobility of LFA-1 in the presence the ICAM-1 nano-aggregates
(see Methods) to test the role of single vs. multi-ligand binding on
the diffusion profile of the receptor.
We first measured the mobility of LFA-1 on resting, non-
stimulated mDCs before and after adding soluble ICAM-1
monomers or nano-aggregates. Since LFA-1 on mDCs is mostly
inactive and unable to bind the ligand, no changes in mobility are
expected. Indeed, the diffusion profiles of LFA-1, i.e., stationary
fraction and mobility (Figures 3A, B) before and after addition of
ICAM-1 remained unchanged, confirming that neither soluble
ICAM-1 monomers, nor nano-aggregates, significantly affect the
mobility of LFA-1 on resting mDCs. These results also indicate
that soluble ligands on their own (either monomeric or clustered)
are not sufficient to trigger integrin activation.
We then measured LFA-1 mobility 2 minutes after adding
together CCL21 and ICAM-1 to mDCs. Interestingly, addition of
monomeric ICAM-1 did not affect LFA-1 lateral diffusion, while
Figure 1. Mobility of LFA-1 on monocytes and mDCs. (A) Representative frame from a recorded movie on a mDC to which SDT was applied
(see Movie S1). Representative examples of stationary, slow and fast trajectories are displayed. (B) Overlay semi-log histogram of LFA-1 diffusion on
both monocytes (dashed black lines) and mDCs (grey bars). (C) Percentage of stationary, slow and fast diffusing LFA-1 molecules on monocytes and
mDCs, as extracted from the cumulative probability distribution analysis (see Methods). (D) Diffusion coefficient of the total mobile population, and
slow and fast diffusing fractions of LFA-1 on monocytes and mDCs. 25 monocytes divided over 6 independent samples (4587 trajectories) and 117
mDCs from 5 different donors, divided over 117 independent samples (26756 trajectories) were imaged. Means 6 SEM are depicted. The Student T-
test was used to determine significant differences between means. The resulting P values are indicated as follows: *P,0.05; ***P,0.0001.
doi:10.1371/journal.pone.0099589.g001
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ICAM-1 nano-aggregates magnified the effect that CCL21 has on
LFA-1 mobility (Figures 3B, D). Indeed, the LFA-1 stationary
fraction increased significantly upon addition of ICAM-1 nano-
aggregates in the presence of CCL21 (Figure 3C), while the
diffusion coefficient of the fast fraction drops considerably
(Figure 3D). Consistent with these results, confocal imaging of
fluorescently labeled ICAM-1 (red) and the quantification of this
fluorescent signal confirms that only the addition of ICAM-1
nano-aggregates in combination with CCL21 activation leads to
significant ligand binding (Figure 3 E–I). The average baseline
fluorescent signal per cell in resting and CCL21 activated cells
with ICAM-1 monomers (which became dimers due to fluorescent
antibody labeling) as well as in resting cells with ICAM-1 nano-
aggregates is similar, while the signal is significantly higher in
CCL21 activated cells with ICAM-1 aggregates (Figure 3E and
Figures 3G–I). Counting the fluorescent spots confirms the
increased binding of ICAM-1 nano-aggregates after CCL21
activation (Figure 3F and Figures 3H–I). Together, these data
show once more the tight correlation between LFA-1 activation
state and lateral mobility on the cell membrane, and importantly
demonstrate that single/dimeric ligand binding in solution is not
sufficient to stabilize the CCL21-triggered high affinity state of
LFA-1 on mDCs, requiring for that receptor clustering via binding
of multiple ligands.
Figure 2. Mobility of LFA-1 on mDCs after activation with CCL21. (A) Overlay histograms of LFA-1 diffusion on monocytes (4578 trajectories),
resting mDCs (26756 trajectories) and CCL21 activated mDCs (4213 trajectories). (B) Percentage of total mobile LFA-1 population (normalized to
100%) displaying slow and fast diffusion on monocytes, mDCs and 2 min CCL21 activated mDCs. (C) Diffusion coefficient of the total mobile
population, and slow and fast diffusing fractions of LFA-1 on monocytes, mDCs and 2 min CCL21 activated mDCs. (D) Stationary fraction of LFA-1 on
monocytes, mDCs and CCL21 activated mDCs, displayed as the difference from the total stationary fraction on mDCs, which serve here as the default.
Data from A–D on CCL21 activated mDCs is based on 22 cells in independent experiments from 3 different donors. (E) Percentage of the stationary,
slow and fast diffusing LFA-1 molecules at different time points after CCL21 activation. (F) D values for the total mobile, and slow and fast fractions of
LFA-1 at different time points after CCL21 activation. Data from E and F is based on 11 cells, 11 independent samples and around 2000 trajectories
per time point. A–F Means 6 SEM are depicted. The One-way ANOVA followed by the Tukey multiple comparison test were used to determine
significant differences between means. The resulting P values are indicated as follows: ns (P.0.05); * (P,0.05) and *** (P,0.0001).
doi:10.1371/journal.pone.0099589.g002
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Figure 3. Mobility of LFA-1 on resting and CCL21-activated mDCs after soluble monomeric and nano-clustered ICAM-1. (A,B) ICAM-1
(either monomeric: ICAMm, or as nano-aggregates: ICAMagg) was added to resting mDCs and mobility was measured before, and between 1 and
5 min after addition. (A) Stationary fraction of LFA-1 molecules on resting mDCs and mDCs + either monomeric ICAM-1 or ICAM-1 nano-aggregates,
displayed as the difference with respect to the total stationary fraction on resting mDCs, which serve here as the default. (B) Diffusion coefficient of
the total mobile population, and slow and fast diffusing fractions of LFA-1 on resting mDCs and after addition of either monomeric ICAM-1 or ICAM-1
nano-aggregates. 30 cells divided over 2 independent experiments (3393 trajectories) were imaged for the ICAMm condition and 10 cells (684
trajectories) for ICAMagg. (C, D) ICAM-1 (either monomeric or nano-aggregates) was added together with CCL21 to mDCs and mobility was
measured before, and 2 minutes after addition. (C) Stationary fraction of LFA-1 molecules on resting mDCs (serving as reference control), CCL21
activated mDCs and CCL21 activated mDCs + either monomeric ICAM-1 or ICAM-1 nano-aggregates, displayed as the difference with respect to the
total stationary fraction on resting mDCs. (D) Diffusion coefficient of the total mobile population, and slow and fast diffusing fractions of LFA-1 on
resting mDCs, CCL21 activated mDCs and after simultaneous addition of CCL21 and either monomeric ICAM-1 or ICAM-1 nano-aggregates. 16 cells
(8423 trajectories) from 2 different donors divided over 5 independent samples (ICAMm) and 7 cells (314 trajectories) from 2 different donors divided
over 7 independent samples (ICAMagg) were imaged. (E) Quantification of fluorescent ICAM-1 dimers (monomers bound together due to antibody
labelling) and nano-aggregates binding in resting and CCL21 activated mDCs, normalized to the area quantified and to the background signal
outside of the cell. For this, regions of the cell in between the obvious fluorescent ICAM-1 aggregates were selected, the fluorescent intensity was
measured using ImageJ, and used to compare the baseline fluorescent signal across all 4 conditions. 20 cells per condition were imaged. (A–E) Means
6 SEM are depicted. The One-way ANOVA followed by the Tukey multiple comparison test were used to determine significant differences between
means. The resulting P values are indicated as follows: ns (P.0.05); * (P,0.05), ** (P,0.001) and *** (P,0.0001). (F) Quantification of bound ICAM-1
nano-aggregates to resting and CCL21 activated mDCs. After applying a threshold of 25% of the fluorescent signal, all visible fluorescent spots per
cell were counted. 20 cells per donor and 3 different donors were imaged. Each data point represents the mean value for 1 donor. Means6 SEM and
individual data points are depicted, and dotted lines connecting datapoint of the same experiment indicate that not just in average, but in each
individual experiment using a different donor, an increase of ICAM-1 nano-aggregate binding is observed after CCL21 activation. The paired two-
tailed Student T-test was used to determine significant differences between means. (G–I) Representative examples of confocal images of ICAM-1
binding to mDCs: (G) dimeric ICAM-1 to resting cells, (H) nano-aggregates of ICAM-1 to resting cells and (I) nano-aggregates to CCL21 activated cells.
Arrows in H and I point to the binding of individual ICAM-1 nano-aggregates to LFA-1.
doi:10.1371/journal.pone.0099589.g003
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Talin1 is Involved in Basal LFA-1 Regulation on Resting
mDCs but not on Monocytes
A major intracellular player known to contribute to integrin
function regulation and activation is Talin1 [24,27–30]. Talin1 is a
cytoplasmic protein that mediates the link between LFA-1 and the
cytoskeleton by binding the b2 subunit of LFA-1 to actin [32,33].
Since we here observed major changes in the fraction of
stationary, cytoskeleton bound LFA-1 molecules between mono-
Figure 4. Localization of Talin1 to LFA-1 on monocytes and mDCs. (A, B) Representative images of (A) a monocyte seeded on a TS2/4
pattern, (B) a resting mDC on irrelevant IgG1 pattern, (C) a resting mDC seeded on a TS2/4 pattern and (D) a CCL21 activated mDC seeded on a
ICAM-1 pattern. Green corresponds to Talin1 and red to the location of IgG1, TS2/4 or ICAM-1 positive squares. Cells are delineated by white lines. (E)
Quantification of the degree of Talin1 enhancement to the positive areas in monocytes in different conditions (see Methods). Mean enhancement
factor is displayed in red per condition. (F) Percentage of positive squares per experiment (n = 3, each a different donor) that showed significantly
enhanced Talin1 signal per condition in monocytes. An enhancement factor of $1.5 was considered significantly enhanced, since 95% of the control
sample (monocytes on IgG1) showed an enhancement factor below this value. (G) Quantification of the degree of Talin1 enhancement to the
positive areas in mDCs in different conditions (see Methods). Mean enhancement factor is displayed in red per condition. (H) Percentage of positive
squares per experiment (n = 3, each a different donor) that showed significantly enhanced Talin1 signal per condition in mDCs. Around 60 cells of 3
different donors were analyzed per condition. Monocytes contained 10 positive areas on average per cell, while mDCs contained around 50 positive
areas. Means6 SEM are depicted. The Kruskal-Wallis test, followed by Dunn’s multiple comparison test was used to determine significant differences
between means in E and G. The One-way ANOVA followed by the Tukey’s multiple comparison test were used to determine significant differences
between means in F and H. The resulting P values are indicated as follows: ns (P.0.05); * (P,0.05) and *** (P,0.0001).
doi:10.1371/journal.pone.0099589.g004
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cytes and mDCs, and between mDCs before and after CCL21
activation and ligand binding, we next sought to investigate the
involvement of Talin1 in this difference. We used microcontact
printing to create square patterns of either TS2/4 binding Abs
against LFA-1 or ligand ICAM-1 on glass coverslips following an
established procedure [41]. As a control, we also used square
patterns of mouse IgG1 isotype control antibodies not specific for
LFA-1. We then seeded the cells on the patterned surfaces. TS2/4
or ICAM-1 on the glass binds to LFA-1 on the cell membrane and
diffusion of the receptor results in accumulation of LFA-1 to the
patterned regions. Talin1 was fluorescently labeled, and the
accumulation of the fluorescent signal to the LFA-1 rich areas was
quantified (Figure 4). In resting as well as CCL21 stimulated
monocytes, a rather diffused distribution of Talin1 was observed
(Figure 4A), independently on whether monocytes were seeded on
a pattern of IgG1, TS2/4 or ICAM-1 (Figure 4E,F). This indicates
that, in our experimental conditions, Talin1 in monocytes does not
preferentially localize to LFA-1, neither in resting state nor upon
ligand binding.
In marked contrast, Talin1 preferentially localized to LFA-1
rich regions on mDCs, even without activation of LFA-1 by
chemokine or ligand binding (Figure 4C–D, G, H). Notice
however that we already observe a basal level of Talin1
accumulation (non-pattern related) close to the substrate that is
aspecific for LFA-1 (Figure 4B). This patchy Talin1 accumulation
might correspond to the formation of podosomes by mDCs [42],
an adhesive structure in which b1 and b3 integrins as well as
Talin1 are involved [43].
In resting mDCs where LFA-1 is specifically recruited to the
TS2/4 positive squares (Figure 4C), Talin1 accumulation to the
patterns was significantly higher than to control IgG1 patterns
(Figure 4G, H). Priming of LFA-1 captured by TS2/4 using
CCL21 does not significantly increase Talin-1 accumulation
beyond that observed in the resting state (Figure 4G, H). These
results thus show a basal association of LFA-1 with Talin1 already
on resting mDCs, which is not affected by transient chemokine
activation of LFA-1.
In resting mDCs seeded on patterns of ICAM-1, a basal Talin1
recruitment similar to that on TS2/4 is observed (Figure 4G, H).
Since ICAM-1 is also a ligand for the aMb2 integrin involved in
podosomes [43], we cannot exclude that the Talin1 recruitment
we observed is only partially LFA-1 specific, especially considering
that LFA-1 on resting mDCs does not bind ICAM-1 very
efficiently [15,18,25]. On the other hand, the combination of both
CCL21 priming and ligand binding highly increases Talin-1
accumulation to the patterns (Figure 4D, G) up to a level where
around 50% of the patterns shows significant enrichment of Talin1
(Figure 4H). This increase is fully LFA-1 specific, since CCL21
does not activate other b2 integrins. These results thus show that
the interaction of Talin1 with LFA-1 is highly increased upon
binding of chemokine primed LFA-1 to ICAM-1, indicating
subsequent anchoring to the cytoskeleton as a result of ligand
binding.
Discussion
We have previously shown that during in vitro differentiation of
monocytes towards immature and mature DCs, LFA-1 remains
expressed at similar levels, but that only monocytes express a
subpopulation of primed and functional LFA-1 [15,18]. Further-
more, one of us recently showed an important role for CCL21 in
the regulation of DC adhesive behavior by modulating LFA-19s
conformation activation state [18]. Although lateral mobility of the
receptor is known to contribute to avidity regulation impacting on
LFA-1 adhesive properties [17], dynamic studies of LFA-1 on
resting and activated mDCs have been lacking so far. In here we
addressed the differential mobility of LFA-1 on mDCs and
compared it to that observed on monocytes. By dynamically
tracing individual LFA-1 molecules on both cell types we now
show that LFA-1 diffusion is significantly faster on mDCs
compared to monocytes. Reactivating LFA-1 on mDCs with
chemokine CCL21 transiently slows down the diffusion of LFA-1
and increases the fraction of stationary molecules. Remarkably,
after 2 minutes of CCL21 stimulation, the diffusion profiles of
LFA-1 on mDCs and monocytes become remarkably similar.
Since a similar transient reactivation of LFA-1 by CCL21 has been
observed at the functional level, namely the binding of the receptor
to its ligand ICAM-1 and the contribution to cell adhesion [25],
our results establish a strong link between LFA-1 function and its
lateral mobility on the cell membrane.
Our results are in full agreement with other recently observed
correlations between reduced mobility and high activity of LFA-1.
Indeed, Cairo et al demonstrated that the mobility of LFA-1 bound
to multivalent ICAM-1 ligands is highly reduced [26]. Moreover,
Rossier et al showed that the average diffusion coefficient of
integrins inside focal adhesions (FAs) is significantly lower
compared to the average coefficient outside FAs, where integrins
do not actively contribute to adhesion [30]. Finally, we recently
showed that upon activation of LFA-1 on monocytes (by Ca2+
removal, Mn2+ or activating antibodies) lateral diffusion becomes
highly impaired [17]. Altogether, these results demonstrate that
integrin immobilization correlates with integrin activation. In
contrast, Constantin et al observed that transient stimulation of
LFA-1 by CCL21 led to the active, high affinity conformation of
the receptor, and the formation of micrometer size LFA-1 clusters.
Based on these data the authors postulated that CCL21-induced
activation of the receptor should be accompanied by a rapid
increase in lateral mobility so that microclusters are quickly
formed [25]. Our results however reflect a higher level of
complexity on LFA-1 function regulation. In fact our data support
a model by which activation of LFA-1 on mDCs by CCL21 results
in a small subset of ‘‘instantaneously’’ immobilized molecules as a
direct result of CCL21 binding to its receptor CCR7, with the
large majority of the remaining LFA-1 molecules still diffusing
across the membrane. This small fraction of stationary molecules
would serve as anchoring points for other diffusing molecules to
become arrested and/or reduce their diffusion, thereby facilitating
clustering. These clusters support the creation of stable adhesion
spots necessary for cell adhesion. This scenario is able to explain
the microclustering observed by Constantin et al, and provides a
rationale as to why the effect of CCL21 is not instantaneous but
takes about two minutes to be fully reached. On monocytes on the
contrary, we previously demonstrated the presence of a subpop-
ulation of primed, stationary LFA-1 nanoclusters on resting cells,
with mobile nanoclusters continuously contributing to cell
adhesion [17,36]. The strong and dynamic interplay between
nanoclustering and mobility might constitute thus a primary
mechanism that differentially regulates LFA-1 activation.
We furthermore investigated the effect of CCL21 in the
presence of the LFA-1 ligand ICAM-1. Based on conformational
data, it has been proposed that binding of LFA-1 to ICAM-1
induces and/or stabilizes its high-affinity conformation [44,45], a
process termed ligand-induced activation. In our experimental
conditions this high-affinity conformation has been transiently
induced by CCL21. We found that soluble monomeric ICAM-1
(in combination with CCL21 stimulation) is not sufficient to
further activate LFA-1 or to stably bind to the receptor. Nano-
aggregates of ICAM-1 on the other hand significantly magnify the
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effect that CCL21 has on LFA-1 mobility and readily bind to LFA-
1. We therefore postulate that ligand induced activation of LFA-1
as reported in literature is actually caused by LFA-1 clustering
promoted by the proximity of multiple ICAM-1 molecules, i.e., a
consequence of avidity. This is in agreement with both the notion
that ligand affinity of LFA-1 is barely increased by chemokine
activation [40], and studies showing that multivalent soluble
ICAM-1 or fixed ICAM-1 substrates at high densities readily lead
to strong immobilization of the receptor and LFA-1 mediated cell
adhesion [26,41].
More recently, it has been postulated that after ICAM-1
binding, postligand binding events must occur in order to fully
bring LFA-1 in the high affinity state [40]. Since monomeric
soluble ligands appear to barely trigger the high affinity of LFA-1
while fixed ligands do, it has been hypothesized that traction forces
resulting from the translational motion of the integrin with respect
to its bound, fixed ligand might contribute to further extend the b2
subunit of the integrin leading to the stabilization of its high
affinity state, i.e. post ligand binding effects. [40]. However, this
hypothesis is difficult to conciliate with abundant recent evidence,
including the results shown in here that demonstrate that ready-to-
bind-integrins are stationary on the cell membrane. With no actual
mobility between the ligand and the receptor, the existence of
traction forces is hard to explain. In the presence of shear forces
however, the force that is needed to reinforce ligand binding does
not come from receptor mobility but from external factors [46,47],
and post-ligand binding events can therefore occur.
One of the major intracellular players known to contribute to
LFA-1 function regulation is Talin1. Knock-down and mutation of
Talin1 has been shown to cause loss of ligand binding capacity of
several b1 and b3 integrins [29,48], leading to a model explaining
integrin activation as an event triggered by structural separation of
the a and the b subunits due to Talin1 binding to the b-leg thereby
inhibiting interaction with the a-leg [28]. In here we show that
activation of LFA-1 by chemokine CCL21 does not increase
Talin1 association to the integrin, unless ligand binding stabilizes
this transient activation. This suggests that Talin1 recruitment to
LFA-1 is a result of integrin activation rather than a trigger
thereof.
We further show preliminary evidence indicating that Talin1
might also play a different and more complex role in the regulation
of b2 integrins like LFA-1. We find that Talin1 already colocalizes
with LFA-1 on mDCs in the resting state prior to integrin
activation. This indicates that Talin1 in b2 integrins is not only
involved in maintaining LFA-1 in the active state, but also
somehow in regulating resting, inactive LFA-1. Others have also
observed association of Talin1 to LFA-1 on resting cells. Sampath
et al showed that b2-integrins on resting neutrophils, which belong
together with DCs to the group of antigen presenting cells in which
LFA-1 is inactive in resting state, co-immunoprecipitates with
Talin1 (225 kDa) [49]. Upon activation, b2 co-immunoprecipi-
tates with a smaller talin1 (190 kDa) that corresponds to the head
domain. In addition, Kim et al showed that transfecting K562 cells
with the Talin1 head domain increases LFA-1 affinity and ligand
binding [44]. Although in our experiments we could not
discriminate between the full Talin1 or its head domain, it is
clear that Talin1 does not exclusively associate to LFA-1 upon
activation, but could instead provide the receptor with the
possibility of becoming activated by additional factors such as
chemokines.
In summary, our results highlight the importance of lateral
mobility of LFA-1 across the membrane on the regulation of
integrin activation and its function as adhesion receptor. We
further demonstrate that chemokines alone are not sufficient to
trigger the high affinity state of the integrin based on the strict
definition that affinity refers to the adhesion capacity of a single
receptor to its ligand in solution. Instead, our results are consistent
with the notion that ligand induced activation of LFA-1 is a
consequence of avidity. Finally, we provide preliminary evidence
for an additional subtler role of Talin1 in regulating LFA-1
activation state, namely by being the agent on which activators
such as chemokines can react to, rather than being the activating
agent itself. We thus identified LFA-1 mobility, ligand binding and
Talin1 recruitment as important players in the tight regulation of
the homing of DCs from distant sites to the lymphatic tissues by
chemokine CCL21.
Supporting Information
Figure S1 Expression level of CCL21 receptor CCR7 on
the membrane of mDCs. Isotype specific control and CCR7
signal are displayed, as well as the MFI of the CCR7 signal.
Histogram is a representative out of 4 experiments.
(TIF)
Figure S2 Control experiment 4 minutes CCL21: per-
centage. Control experiments showing the percentage of the
stationary, slow and fast diffusing LFA-1 on mDCs without
CCL21 stimulation, at different time points. 6 cells (around 1000
trajectories) were measured per time point. Means 6 SEM are
depicted. The One-way ANOVA followed by the Tukey multiple
comparison test were used to determine significant differences
between means. The resulting P values are indicated as follows: ns
(P.0.05); * (P,0.05) and *** (P,0.0001).
(TIF)
Figure S3 Control experiment 4 minutes CCL21: D.
Control experiments showing the D values for the total mobile,
and slow and fast fractions of LFA-1 on mDCs without CCL21
stimulation, at different time points. 6 cells (around 1000
trajectories) were measured per time point. Means 6 SEM are
depicted. The One-way ANOVA followed by the Tukey multiple
comparison test were used to determine significant differences
between means. The resulting P values are indicated as follows: ns
(P.0.05); * (P,0.05) and *** (P,0.0001).
(TIF)
Movie S1 Single LFA-1 mobility on mDCs. Representative
movie of TS2/4-ATTO647N labeled LFA-1 on a mDC to which
SDT was applied. Individual fluorescent spots correspond to
diffusive or stationary LFA-1 molecules. The background at the
centre of the movie corresponds to the nucleus. Image area:
39633 mm2 Frame rate: 10 Hz. Length of movie: 200 frames.
(AVI)
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